Polytherapy and Potential Drug–Drug Interactions in Geriatric Patients of a Tertiary-care Hospital

Introduction: Polytherapy, the concomitant use of five or more drugs, is a prevalent public health problem, especially in the elderly. The elderly are susceptible to multiple chronic illnesses, which makes the use of polytherapy inevitable; however, it increases the risk of potential drug–drug interactions (PDDIs). Moreover, the use of multiple medications not only increases the risk of PDDIs but also the use of potentially inappropriate medication (PIM), medication non-adherence leading to skipped doses/overdoses. The aim of this study was to investigate the polytherapy prevalence and its implications, such as PDDIs, prevalence of PIM using the Beers Criteria-2023, and analyse the fixed-dose combinations (FDC) prescribed to the elderly. Methods: A retrospective cross-sectional study was conducted on 100 patients visiting the geriatric OPD in a tertiary-care hospital in Gujarat, India. Prescription data were analysed for PDDIs using Medscape.com. PIM analysis was done using the AGS-Beers Criteria-2023. Lastly, all FDCs prescribed to patients were checked for their inclusion in the WHO Essential Medicines List-2025/National List of Essential Medicines-2022. Results: It was found that 80% (95% CI: 72%–88%) of the patients were on polytherapy. Drugs affecting the cardiovascular system were the most prescribed. A total of 537 PDDIs were flagged, with 99.07% of those flagged in patients with polytherapy. It was also found that 78.38% (95% CI: 69.0%–87.8%) of the patients aged 65+ were on at least one PIM, with the most common PIM being proton-pump inhibitors and benzodiazepines/z-drugs. Additionally, only 23.29% of the different FDCs prescribed to patients were included in either the WHO EML-2025 or NLEM-2022. Conclusion: This research underscores high polytherapy prevalence, calling for vigilant policies on rational prescribing, practice of evidence-based medicine, medication reviews, and strict policies on FDC formulation.

Authors

Institutions

Publication Details

Journal
Apollo Medicine
Published
2026-05-29
DOI
https://doi.org/10.1177/09760016261453160
Primary Topic
Pharmaceutical Practices and Patient Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Polytherapy and Potential Drug–Drug Interactions in Geriatric Patients of a Tertiary-care Hospital

Jiya Thosar, Shivangi Shukla, Supriya Malhotra, Ami Parikh
Apollo Medicine
Pharmaceutical Practices and Patient Outcomes
article

Polytherapy and Potential Drug–Drug Interactions in Geriatric Patients of a Tertiary-care Hospital

Jiya Thosar, Shivangi Shukla, Supriya Malhotra, Ami Parikh
article en

Abstract

Introduction: Polytherapy, the concomitant use of five or more drugs, is a prevalent public health problem, especially in the elderly. The elderly are susceptible to multiple chronic illnesses, which makes the use of polytherapy inevitable; however, it increases the risk of potential drug–drug interactions (PDDIs). Moreover, the use of multiple medications not only increases the risk of PDDIs but also the use of potentially inappropriate medication (PIM), medication non-adherence leading to skipped doses/overdoses. The aim of this study was to investigate the polytherapy prevalence and its implications, such as PDDIs, prevalence of PIM using the Beers Criteria-2023, and analyse the fixed-dose combinations (FDC) prescribed to the elderly. Methods: A retrospective cross-sectional study was conducted on 100 patients visiting the geriatric OPD in a tertiary-care hospital in Gujarat, India. Prescription data were analysed for PDDIs using Medscape.com. PIM analysis was done using the AGS-Beers Criteria-2023. Lastly, all FDCs prescribed to patients were checked for their inclusion in the WHO Essential Medicines List-2025/National List of Essential Medicines-2022. Results: It was found that 80% (95% CI: 72%–88%) of the patients were on polytherapy. Drugs affecting the cardiovascular system were the most prescribed. A total of 537 PDDIs were flagged, with 99.07% of those flagged in patients with polytherapy. It was also found that 78.38% (95% CI: 69.0%–87.8%) of the patients aged 65+ were on at least one PIM, with the most common PIM being proton-pump inhibitors and benzodiazepines/z-drugs. Additionally, only 23.29% of the different FDCs prescribed to patients were included in either the WHO EML-2025 or NLEM-2022. Conclusion: This research underscores high polytherapy prevalence, calling for vigilant policies on rational prescribing, practice of evidence-based medicine, medication reviews, and strict policies on FDC formulation.

Apollo Medicine
Smt. N.H.L. Municipal Medical College (IN)
Openalex Percentile: Top 7%
Pharmaceutical Practices and Patient Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.